Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
| Image |  |
|---|---|
| Description | scientific article published on January 2005 |
| Author/s |
author: Alexander Schmittel Anne Marie Asemissen Carmen Scheibenbogen Fredrik B. Thorén Anne Letsch Ulrich Keilholz Kristoffer Hellstrand |
| Publication date | January 1, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |